BBVA
VBIV

Banco Bilbao Vizcaya Argentaria’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,333
Closed -$353K – 775
2020
Q2 		$353K Hold
3,333
– – 0.01% 608
2020
Q1 		$338K Buy
+3,333
New +$130K 0.01% 554

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's VBIV Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2020, closing a stake of 3,333 shares — an estimated $353K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in VBIV in Q1 2020 and held it in 2 quarters. The position peaked at $353K in Q2 2020. 114 funds tracked by Wall St. Rank hold VBIV as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 3,333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2020, an estimated $353K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2020 and held it in 2 quarters.
  • Banco Bilbao Vizcaya Argentaria's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $353K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.